X. Rosa Ma,Stephanie D. Conley,Michael Kosicki,Danila Bredikhin,Ran Cui,Steven Tran,Maya U. Sheth,Wei-Lin Qiu,Sijie Chen,Soumya Kundu,Helen Y. Kang,Dulguun Amgalan,Chad J. Munger,Lauren Duan,Katherine Dang,Oriane Matthys Rubio,Shinwan Kany,Siavash Zamirpour,John DePaolo,Arun Padmanabhan,Birth Defects Research Laboratory,Jeffrey Olgin,Scott Damrauer,Robin Andersson,Mingxia Gu,James R. Priest,Thomas Quertermous,Xiaojie Qiu,Marlene Rabinovitch,Axel Visel,Len Pennacchio,Anshul Kundaje,Ian A. Glass,Casey A. Gifford,James P. Pirruccello,William R. Goodyer,Jesse M. Engreitz

Abstract:Congenital heart defects (CHD) arise in part due to inherited genetic variants that alter genes and noncoding regulatory elements in the human genome. These variants are thought to act during fetal development to influence the formation of different heart structures. However, identifying the genes, pathways, and cell types that mediate these effects has been challenging due to the immense diversity of cell types involved in heart development as well as the superimposed complexities of interpreting noncoding sequences. As such, understanding the molecular functions of both noncoding and coding variants remains paramount to our fundamental understanding of cardiac development and CHD. Here, we created a gene regulation map of the healthy human fetal heart across developmental time, and applied it to interpret the functions of variants associated with CHD and quantitative cardiac traits. We collected single-cell multiomic data from 734,000 single cells sampled from 41 fetal hearts spanning post-conception weeks 6 to 22, enabling the construction of gene regulation maps in 90 cardiac cell types and states, including rare populations of cardiac conduction cells. Through an unbiased analysis of all 90 cell types, we find that both rare coding variants associated with CHD and common noncoding variants associated with valve traits converge to affect valvular interstitial cells (VICs). VICs are enriched for high expression of known CHD genes previously identified through mapping of rare coding variants. Eight CHD genes, as well as other genes in similar molecular pathways, are linked to common noncoding variants associated with other valve diseases or traits via enhancers in VICs. In addition, certain common noncoding variants impact enhancers with activities highly specific to particular subanatomic structures in the heart, illuminating how such variants can impact specific aspects of heart structure and function. Together, these results implicate new enhancers, genes, and cell types in the genetic etiology of CHD, identify molecular convergence of common noncoding and rare coding variants on VICs, and suggest a more expansive view of the cell types instrumental in genetic risk for CHD, beyond the working cardiomyocyte. This regulatory map of the human fetal heart will provide a foundational resource for understanding cardiac development, interpreting genetic variants associated with heart disease, and discovering targets for cell-type specific therapies.

In Silico Analyses Reveal the Relationship Between SIX1/EYA1 Mutations and Conotruncal Heart Defects

Analysis of Pathogenic Variants in 605 Chinese Children with Non-Syndromic Cardiac Conotruncal Defects Based on Targeted Sequencing.

Identification of FOXH1 Mutations in Patients with Sporadic Conotruncal Heart Defect

TBX1 Loss-of-function Mutation Contributes to Congenital Conotruncal Defects

Identification of TBX2 and TBX3 Variants in Patients with Conotruncal Heart Defects by Target Sequencing

Identification of two novel GATA6 mutations in patients with nonsyndromic conotruncal heart defects.

Targeted Sequencing Identifies Novel GATA6 Variants in a Large Cohort of Patients with Conotruncal Heart Defects.

EP06.06: Analysis of Copy Number Variations in Fetal Conotruncal Heart Defects Using Low‐coverage Whole Genome Sequencing

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

Variants in FOXC1 and FOXC2 Identified in Patients with Conotruncal Heart Defects

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Identification of ZFPM2 Mutations in Sporadic Conotruncal Heart Defect Patients

Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

Genetic Analysis of Rare Coding Mutations of CELSR1-3 in Congenital Heart and Neural Tube Defects in Chinese People.

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects

Novel Mutations of the SRF Gene in Chinese Sporadic Conotruncal Heart Defect Patients

Deletion of Ets-1, A Gene in the Jacobsen Syndrome Critical Region, Causes Ventricular Septal Defects and Abnormal Ventricular Morphology in Mice